Data / Form D filings / nanoRETE, Inc.
nanoRETE, Inc.: Form D filing
nanoRETE, Inc., a biotechnology company in Lansing, MI, filed a Form D with the SEC in 2012. The latest, on December 21, 2012, reports $1.2 million sold of a $3 million offering to 3 investors.
Find out what nanoRETE, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3815 TECHNOLOGY BOULEVARD, SUITE 1050, Lansing, MI, 48910
- Phone
- (734) 223-2591
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1565191
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 21, 2012 | New notice | $3,000,000 | $1,188,277 | $1,811,723 | 3 | Dec 10, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fred Beyerlein | Executive Officer, Director | |
| Houng-Yau Mei | Executive Officer | |
| Dale Grogan | Director | |
| John Kerschen | Director | |
| Julia Bradsher | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Dec 17, 2012 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what nanoRETE, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.